New Business Development Director at SOLVO Biotechnology

SOLVO Biotechnology has appointed Berend Oosterhuis as Business Development Director

Since its establishment in 1999, SOLVO Biotechnology - "The Transporter Company" - has become the main provider of transporter related products and services in pharmaceutical R&D, and won great renown among its clients for its knowledge and expertise in the field.

Mr. Oosterhuis began his career at SOLVO in 2005 as a scientist in the Research and Development Laboratory, where he worked on various research projects and was involved in the publication of several scientific papers. Before promoted to BD Director, he served as the Head of the Service Laboratory, and gained valuable knowledge about the ADME-Tox market and the role of transporter proteins in it.

In his new position, Mr. Oosterhuis will focus on continuing to build SOLVO's reputation as a highly appreciated partner in ADME-Tox related transporter studies in the pharmaceutical and biotechnology community.

As the new Business Development Director of SOLVO Biotechnology, he will be responsible for the marketing and sales operations of the company, with an aim to contribute to the strategic growth of SOLVO's product and service portfolio. Having first-hand experience both in researching and performing services for clients, he will definitely be able to promote SOLVO's scientific expertise from 'inside out'.

Mr. Oosterhuis holds a Master's Degree in Biotechnology from the Wageningen University and Research Centre.

Looking forward to further beneficial co-operation.

With our best regards,
SOLVO Biotechnology
Business Development Team

CONTACT INFORMATION:

SOLVO Biotechnology
2 Gyár St. H-2040 Budaörs, HUNGARY
E-mail: sales@solvo.com
web: www.solvo.com
Phone: +36-23/503-940
Fax: +36-23/503-941

SOLVO distributors:
in US and Canada: XenoTech LLC www.xenotechllc.com,
in Europe: SOLVO and Tebu-bio www.tebu-bio.com,
in Japan: Nosan www.nosan.co.jp,
in India: Krishgen www.krishgen.com

Privileged/confidential information may be contained in this message. This communication is confidential and intended solely for the addressee(s). Unauthorized distribution, modification or disclosure of the contents may be unlawful. If you receive this in error, please notify the sender and delete it from your system. If you are not the addressee indicated in this message (or responsible for delivery of the message to such person), you may not copy or deliver this message to anyone.

If you wish to unsubscribe, please send a letter to

with 'unsubscribe' in the subject field.